{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:18:35Z","timestamp":1790050715324,"version":"4.0.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CSAINV17nov016"],"award-info":[{"award-number":["CSAINV17nov016"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["WBS R-179-000-063-213"],"award-info":[{"award-number":["WBS R-179-000-063-213"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T18:38:22Z","timestamp":1574447902000},"page":"111-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Epstein\u2013Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach"],"prefix":"10.1016","volume":"52","author":[{"given":"Susan Swee-Shan","family":"Hue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-3361","authenticated-orcid":false,"given":"Ming Liang","family":"Oon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8335-4178","authenticated-orcid":false,"given":"Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Yong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-6410","authenticated-orcid":false,"given":"Siok-Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.011_bib1","series-title":"Hematopathology","first-page":"565","article-title":"Virally associated T-cell and NK-cell neoplasms","author":"Ko","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib2","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"355","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood","author":"Quintanilla-Martinez","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib3","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"353","article-title":"Aggressive NK-cell leukaemia","author":"Chan","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib4","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"368","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib5","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"403","article-title":"Peripheral T-cell lymphoma, NOS","author":"Pileri","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pathol.2019.09.011_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pathol.2019.09.011_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2016.00047","article-title":"Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment","volume":"4","author":"Ishii","year":"2016","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pathol.2019.09.011_bib10","first-page":"29","article-title":"Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL study group of the histiocyte society","volume":"18","author":"Henter","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes \u2013 an update","volume":"28","author":"Janka","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.pathol.2019.09.011_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pathol.2019.09.011_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/ejh.12399","article-title":"Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party","volume":"94","author":"Koh","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","article-title":"Clinical features and treatment strategies of Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"44","author":"Imashuku","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK\u2013cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1040-8428(02)00119-1","article-title":"Cell type specific infection of Epstein\u2013Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"44","author":"Kasahara","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib18","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.cca.2011.04.036","article-title":"Detection of T-cell receptor gene rearrangement in children with Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis","volume":"412","author":"Matsuda","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pathol.2019.09.011_bib19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/pbc.24980","article-title":"Prognostic factors of Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan histiocytosis study group","volume":"61","author":"Kogawa","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pathol.2019.09.011_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jpeds.2013.06.053","article-title":"Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment","volume":"163","author":"Chandrakasan","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pathol.2019.09.011_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pathol.2019.09.011_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pathol.2019.09.011_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","article-title":"Clinical features of adult-onset chronic active Epstein\u2013Barr virus infection: a retrospective analysis","volume":"93","author":"Arai","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2019.09.011_bib26","first-page":"503","article-title":"Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders","volume":"15","author":"Nitta","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(99)70210-0","article-title":"Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy","volume":"40","author":"Iwatsuki","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1525-1470.2010.01094.x","article-title":"Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children","volume":"27","author":"Xu","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1600-0560.2007.00836.x","article-title":"Hydroa-like lymphoma with CD56 expression","volume":"35","author":"Doeden","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/PAS.0b013e3181fbb4fd","article-title":"EBV-associated cutaneous NK\/T-cell lymphoma: review of a series of 14 cases from Peru in children and young adults","volume":"34","author":"Rodriguez-Pinilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00129039-200203000-00002","article-title":"Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru","volume":"10","author":"Barrionuevo","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.pathol.2019.09.011_bib33","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib34","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/jid.2011.461","article-title":"Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected gammadeltaT cells","volume":"132","author":"Hirai","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib35","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","article-title":"Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases","volume":"151","author":"Cho","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archderm.1990.01670270094016","article-title":"Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis","volume":"126","author":"Tokura","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaci.2005.04.044","article-title":"Chronic active Epstein-Barr virus infection of natural killer cells presenting as severe skin reaction to mosquito bites","volume":"116","author":"Pacheco","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pathol.2019.09.011_bib38","first-page":"e173","article-title":"Epstein\u2013Barr virus infected natural killer cell lymphoma in a patient with hypersensitivity to mosquito bite","volume":"52","author":"Cho","year":"2006","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.pathol.2019.09.011_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2006.11.002","article-title":"Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis","volume":"45","author":"Asada","year":"2007","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.pathol.2019.09.011_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1067\/mjd.2001.114751","article-title":"Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia\/lymphoma","volume":"45","author":"Tokura","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pathol.2019.09.011_bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib42","first-page":"1219","article-title":"Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan","volume":"144","author":"Su","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib43","first-page":"7110","article-title":"Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome","volume":"7","author":"Chen","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib44","first-page":"5738","article-title":"The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder","volume":"7","author":"Smith","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib45","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?","volume":"16","author":"Kimura","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.pathol.2019.09.011_bib47","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3324\/haematol.11147","article-title":"Association of transforming growth factor-\u03b21 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases","volume":"92","author":"Hatta","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.011_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13023-014-0165-x","article-title":"Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T\/NK lymphoproliferative disease in non-immunocompromised hosts","volume":"9","author":"Ng","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pathol.2019.09.011_bib49","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.3109\/10428194.2014.983099","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer\/T-cell lymphoma but shows distinctive stem cell-like phenotype","volume":"56","author":"Ng","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.011_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.micinf.2014.04.004","article-title":"PCR array analysis of gene expression profiles in chronic active Epstein-Barr virus infection","volume":"16","author":"Murakami","year":"2014","journal-title":"Microbe Infect"},{"key":"10.1016\/j.pathol.2019.09.011_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fped.2018.00405","article-title":"Transcriptomic abnormalities in Epstein Barr virus associated T\/NK lymphoproliferative disorders","volume":"6","author":"de Mel","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pathol.2019.09.011_bib52","first-page":"77","article-title":"Natural killer cell neoplasms","volume":"3","author":"Chan","year":"1998","journal-title":"Anat Pathol Chic Ill Annu"},{"key":"10.1016\/j.pathol.2019.09.011_bib53","first-page":"1343","article-title":"Aggressive natural killer cell leukemia: clinical features and treatment outcome","volume":"87","author":"Song","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.011_bib54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.011_bib55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.trsl.2014.01.010","article-title":"Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia","volume":"163","author":"Li","year":"2014","journal-title":"Transl Res"},{"key":"10.1016\/j.pathol.2019.09.011_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1532\/IJH97.A10612","article-title":"Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature","volume":"85","author":"Ryder","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib57","first-page":"3423","article-title":"Six cases of aggressive natural killer-cell leukemia in a Chinese population","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib58","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1080\/10428190400004513","article-title":"Aggressive natural killer-cell leukemia: report of five cases and review of the literature","volume":"45","author":"Ruskova","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.011_bib59","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib60","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1182\/blood.V79.8.2116.2116","article-title":"Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells","volume":"79","author":"Hart","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI114168","article-title":"CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA","volume":"84","author":"Kawa-Ha","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2019.09.011_bib62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","article-title":"Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.pathol.2019.09.011_bib63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: clinical, pathologic, and genetic features","volume":"41","author":"Nicolae","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib64","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0000000000000634","article-title":"Clinicopathologic characterization of aggressive natural killer cell leukemia involving different tissue sites","volume":"40","author":"Gao","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib65","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2013.819577","article-title":"Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan","volume":"55","author":"Kimura","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.011_bib66","doi-asserted-by":"crossref","first-page":"E1931","DOI":"10.3390\/ijms19071931","article-title":"The genomics and molecular biology of natural killer\/T-cell lymphoma: opportunities for translation","volume":"19","author":"de Mel","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2019.09.011_bib67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2019.09.011_bib68","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2019.09.011_bib69","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fped.2018.00292","article-title":"Aggressive NK-cell leukemia","volume":"6","author":"Ishida","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pathol.2019.09.011_bib70","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/modpathol.2017.37","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: a clinical and pathological study from a single institution","volume":"30","author":"Gao","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-016-0271-4","article-title":"l -asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia","volume":"9","author":"Jung","year":"2016","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib72","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbmt.2017.01.082","article-title":"Allogeneic hematopoietic cell transplantation for aggressive NK cell leukemia. A center for international blood and marrow transplant Research analysis","volume":"23","author":"Hamadani","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pathol.2019.09.011_bib73","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib74","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib75","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clon.2008.05.011","article-title":"A\u00a0clinical study of 115 patients with extranodal natural killer\/T-cell lymphoma, nasal type","volume":"20","author":"Wu","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib76","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/PAS.0000000000001210","article-title":"De novo testicular extranodal NK\/T-cell lymphoma: a clinicopathologic study of 21 cases with review of additional 18 cases in the literature","volume":"43","author":"Huang","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib77","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2141.1997.1462962.x","article-title":"CD56+ NK lymphomas:clinicopathological features and prognosis","volume":"97","author":"Kwong","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10147-009-0882-7","article-title":"Nasal natural killer (NK)\/T-cell lymphoma: clinical, histological, virological, and genetic features","volume":"14","author":"Harabuchi","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.humpath.2014.11.008","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors","volume":"46","author":"Jhuang","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib80","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3109\/10428194.2014.974048","article-title":"Prognostic implications of CD30 expression in extranodal natural killer\/T-cell lymphoma according to treatment modalities","volume":"56","author":"Kim","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.011_bib81","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2016.47","article-title":"Nasal-type NK\/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior","volume":"29","author":"Hong","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib82","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.09.011_bib83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib84","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.011_bib85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and ab, gd, and ab\/gd T-cell origin: a comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib86","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.4161\/cc.7.22.7120","article-title":"Epstein-Barr virus-mediated dysregulation of human microRNA expression","volume":"7","author":"Godshalk","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pathol.2019.09.011_bib87","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1093\/nar\/gkn666","article-title":"Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway","volume":"36","author":"Gatto","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pathol.2019.09.011_bib88","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2010-06-292268","article-title":"A\u00a0novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy","volume":"116","author":"Fox","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib89","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","article-title":"Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in\u00a0vitro","volume":"25","author":"Iqbal","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.011_bib90","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","article-title":"Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling","volume":"223","author":"Ng","year":"2011","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib91","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-018-0678-1","article-title":"Advances in multiple omics of natural-killer\/T cell lymphoma","volume":"11","author":"Xiong","year":"2018","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0716-7","article-title":"Molecular pathogenic pathways in extranodal NK\/T cell lymphoma","volume":"12","author":"de Mel","year":"2019","journal-title":"J\u00a0Hematol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2019.09.011_bib94","first-page":"2814","article-title":"Daratumumab efficiently targets NK\/T cell lymphoma with high CD38 expression","volume":"130","author":"Mustafa","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib95","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMc1605684","article-title":"Targeting CD38 in refractory extranodal natural killer cell-T-cell lymphoma","volume":"375","author":"Hari","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.011_bib96","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00277-015-2359-2","article-title":"CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK\/T cell lymphoma, nasal type","volume":"94","author":"Wang","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00277-016-2818-4","article-title":"Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK\/T-cell lymphoma, nasal type","volume":"96","author":"Jo","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib98","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00262-017-1987-x","article-title":"Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer\/T-cell lymphoma: a potential rationale for immunotherapy","volume":"66","author":"Nagato","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.pathol.2019.09.011_bib99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00428-016-2011-0","article-title":"Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK\/T cell lymphoma is associated with better prognosis","volume":"469","author":"Kim","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2019.09.011_bib101","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-018-0559-7","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma","volume":"11","author":"Li","year":"2018","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.pathol.2019.09.011_bib103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-017-3127-2","article-title":"PD1 blockade with low-dose nivolumab in NK\/T cell lymphoma failing l-asparaginase: efficacy and safety","volume":"97","author":"Chan","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib104","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2012.04199.x","article-title":"Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases","volume":"61","author":"Kato","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.011_bib105","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","article-title":"Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features","volume":"46","author":"Jeon","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib106","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","article-title":"T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases","volume":"39","author":"Kato","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib107","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward \u2013 report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.011_bib108","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00000478-199910000-00003","article-title":"Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients","volume":"23","author":"Kagami","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib109","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.prp.2013.04.013","article-title":"Epstein\u2013Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study","volume":"209","author":"Ha","year":"2013","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2019.09.011_bib110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.011_bib111","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12185-016-2068-1","article-title":"Clinical features and treatment outcome of Epstein\u2013Barr virus-positive nodal T-cell lymphoma","volume":"104","author":"Jung","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beha.2013.04.002","article-title":"Epstein\u2013Barr virus-associated natural killer\/T-cell lymphomas","volume":"26","author":"Asano","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib113","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.5858\/arpa.2011-0145-RA","article-title":"Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis","volume":"135","author":"Burke","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2019.09.011_bib114","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"372","article-title":"Intestinal T-cell lymphoma","author":"Jaffe","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib115","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","article-title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","volume":"117","author":"Mansoor","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.011_bib116","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression","volume":"35","author":"Chan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib117","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","article-title":"Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8\u03b1\u03b1 phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.011_bib118","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1002\/ajh.23324","article-title":"Diagnosis of type II enteropathy-associated T-cell lymphoma should be limited to EBER\u2212 cases","volume":"87","author":"Tan","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib119","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/leu.2010.295","article-title":"Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma","volume":"25","author":"Tan","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.011_bib120","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"381","article-title":"Hepatosplenic T-cell lymphoma","author":"Gaulard","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib121","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"348","article-title":"T-cell large granular lymphocytic leukaemia","author":"Chan","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib122","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"351","article-title":"Chronic lymphoproliferative disorder of NK cells","author":"Villamor","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.011_bib123","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ejh.13038","article-title":"Chronic lymphoproliferative disorder of NK-cells: a single-institution review with emphasis on relative utility of multimodality diagnostic tools","volume":"100","author":"Kurt","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.pathol.2019.09.011_bib124","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.011_bib125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428190009058510","article-title":"Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases","volume":"37","author":"Imashuku","year":"2000","journal-title":"Leuk Lymphoma"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:54:55Z","timestamp":1778651695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519304210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519304210"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.011","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein\u2013Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}